Sorry, you need to enable JavaScript to visit this website.

Study to Evaluate the Safety of Combinations of Avelumab, Binimetinib and Talazoparib in Patients With Advanced Cancer

A Phase 1B/2 Study to Evaluate Safety and Clinical Activity of Combinations of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or
Metastatic RAS-Mutant Solid Tumors

Category & Conditions: Cancer
Medicine: BAVENCIO(AVELUMAB) MEKTOVI® TABLETS(BINIMETINIB) Talzenna (talazoparib) Identifier (NCT): NCT03637491
Protocol ID: B9991033
Open Plain Language Summary Result: Click here